Pathology of the 21st Century: From Molecular Diagnostics to Personalized Cancer Therapy
Pathology of the 21st Century (P21) is an international program at MD Anderson that emphasizes the use of innovative diagnostic tools for neoplastic disorders and new neoplastic entities and classification systems. The Biennial Pathology Symposium of M. D. Anderson Cancer Center-Chinese Sister Institutions was first held in partnership with MD Anderson’s sister institute, Fudan University Shanghai Cancer Center in Shanghai in 2005. As one of MD Anderson’s sister institutes in China, Sun Yat-sen University Cancer Center is honored to host this year’s combined biennial pathology symposium and P21 conference in China.
The main theme of this conference is novel approaches to the pathological diagnosis and classification of tumors. The conference topics will cover a wide spectrum of neoplastic diseases, such as gynecological tumors, gliomas, thyroid neoplasia, melanocytic lesions, neuroendocrine tumors, colorectal cancer, and prostate cancer. Particular attention will be given to molecular and cytogenetic testing in pathological diagnosis and personalized therapy. Relevant topics, such as the application of and approach to immunohistochemical analyses in tumor pathology and the training of pathologists in the 21st century, will also be presented. Thirteen leading pathologists from MD Anderson and several renowned Chinese pathologists will present lectures and interact with attendees to explore the development of pathology in the 21st century.
Online registration at http://pathology21.sysucc.org.cn
Registration deadline: May 15, 2013